BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
+14.45%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$128M
AUM Growth
+$128M
Cap. Flow
+$4.59M
Cap. Flow %
3.59%
Top 10 Hldgs %
70.42%
Holding
59
New
8
Increased
11
Reduced
8
Closed
1

Top Buys

1
SILK
Silk Road Medical, Inc. Common Stock
SILK
$1.43M
2
PHR icon
Phreesia
PHR
$741K
3
STOK icon
Stoke Therapeutics
STOK
$658K
4
TXG icon
10x Genomics
TXG
$504K
5
CHRS icon
Coherus Oncology, Inc. Common Stock
CHRS
$366K

Top Sells

1
INBX
Inhibrx, Inc. Common Stock
INBX
$836K
2
BMY icon
Bristol-Myers Squibb
BMY
$718K
3
BLUE
bluebird bio
BLUE
$185K
4
TSVT
2seventy bio
TSVT
$171K
5
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
$122K

Sector Composition

1 Healthcare 95.37%
2 Energy 4.62%
3 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TVTX icon
26
Travere Therapeutics
TVTX
$1.56B
$1.1M 0.86% 122,000 +40,000 +49% +$360K
APLS icon
27
Apellis Pharmaceuticals
APLS
$3.48B
$1.08M 0.84% 18,000 – –
AXDX
28
DELISTED
Accelerate Diagnostics
AXDX
$883K 0.69% 225,239 – –
PXD
29
DELISTED
Pioneer Natural Resource Co.
PXD
$855K 0.67% 3,800 – –
DCGO icon
30
DocGo
DCGO
$153M
$839K 0.66% 150,000 +20,000 +15% +$112K
PGNY icon
31
Progyny
PGNY
$2.04B
$818K 0.64% 22,000 +4,000 +22% +$149K
ARVN icon
32
Arvinas
ARVN
$568M
$617K 0.48% 15,000 – –
KNSA icon
33
Kiniksa Pharmaceuticals
KNSA
$2.48B
$526K 0.41% 30,000 – –
KALV icon
34
KalVista Pharmaceuticals
KALV
$678M
$490K 0.38% 40,000 – –
XENE icon
35
Xenon Pharmaceuticals
XENE
$2.98B
$461K 0.36% 10,000 – –
BLUE
36
DELISTED
bluebird bio
BLUE
$443K 0.35% 321,200 -134,000 -29% -$185K
KPTI icon
37
Karyopharm Therapeutics
KPTI
$61.7M
$406K 0.32% 469,832 -102,000 -18% -$88.2K
FOLD icon
38
Amicus Therapeutics
FOLD
$2.34B
$397K 0.31% 28,000 – –
HALO icon
39
Halozyme
HALO
$8.56B
$370K 0.29% 10,000 – –
CHRS icon
40
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$366K 0.29% +110,000 New +$366K
SWTX
41
DELISTED
SpringWorks Therapeutics
SWTX
$365K 0.29% +10,000 New +$365K
BHVN
42
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$315K 0.25% +7,365 New +$315K
KROS icon
43
Keros Therapeutics
KROS
$618M
$278K 0.22% 7,000 – –
XNCR icon
44
Xencor
XNCR
$580M
$261K 0.2% 12,300 – –
CGEM icon
45
Cullinan Oncology
CGEM
$445M
$256K 0.2% 25,114 – –
GTHX
46
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$244K 0.19% 80,000 -40,000 -33% -$122K
ZNTL icon
47
Zentalis Pharmaceuticals
ZNTL
$122M
$242K 0.19% +16,000 New +$242K
SRPT icon
48
Sarepta Therapeutics
SRPT
$1.78B
$241K 0.19% 2,500 – –
LQDA icon
49
Liquidia Corp
LQDA
$2.38B
$241K 0.19% +20,000 New +$241K
CABA icon
50
Cabaletta Bio
CABA
$133M
$227K 0.18% +10,000 New +$227K
1
2
3